Probiotics and Antimicrobial Proteins · 2021 · 22 citations · 41 references
Life SciencesMicrobiologyNutritionClinical NutritionHuman NutritionMicrobiome ResearchGut MicrobiomeGut MicrobiotaHost-microbiome InteractionsMicrobiome DysbiosisMicrobiome FunctionProbioticsGut Microbiome AlterationsGut Microbiome DiversityGut Microbiome DysbiosisGut Microbiota DysbiosisGut Microbiota EffectsInfant Gut MicrobiotaPrader-willi Syndrome TreatmentProbiotic Effects On Gut Microbiota
Abstract Prader–Willi syndrome (PWS) is a rare genetic disorder associated with developmental delay, obesity, and neuropsychiatric comorbidities. Limosilactobacillus reuteri ( Lactobacillus reuteri , Lact. reuteri ) has demonstrated anti-obesity and anti-inflammatory effects in previous studies. In the present study, we aim to evaluate the effects of Lact. reuteri supplementation on body mass index (BMI), social behaviors, and gut microbiota in individuals with PWS. We conducted a 12-week, randomized, double-blind, placebo-controlled trial in 71 individuals with PWS aged 6 to 264 months (64.4 ± 51.0 months). Participants were randomly assigned to either receive daily Lact. reuteri LR-99 probiotic (6 × 10 10 colony forming units) or a placebo sachet. Groupwise differences were assessed for BMI, ASQ-3, and GARS-3 at baseline, 6 weeks, and 12 weeks into treatment. Gut microbiome data was analyzed with the QIIME2 software package, and predictive functional profiling was conducted with PICRUSt-2. We found a significant reduction in BMI for the probiotic group at both 6 weeks and 12 weeks relative to the baseline ( P < 0.05). Furthermore, we observed a significant improvement in social communication and interaction, fine motor function, and total ASQ-3 score in the probiotics group compared to the placebo group ( P < 0.05). Altered gut microbiota was observed in the probiotic group to favor weight loss and improve gut health. The findings suggest a novel therapeutic potential for Lact. reuteri LR-99 probiotic to modulate BMI, social behaviors, and gut microbiota in Prader–Willi syndrome patients, although further investigation is warranted. Trial registration Chinese Clinical Trial Registry: ChiCTR1900022646
41
KEGG as a reference resource for gene and protein annotation
Minoru Kanehisa, Yoko Sato, Masayuki Kawashima et al. · Nucleic Acids Research · 2015 · 7.9K citations · Full text
WHO Child Growth Standards based on length/height, weight and age
Mercedes de Onís · Acta Paediatrica · 2006 · 4K citations
Multivariable association discovery in population-scale meta-omics studies
Himel Mallick, Ali Rahnavard, Lauren J. McIver et al. · PLoS Computational Biology · 2021 · 2.4K citations · Full text
Deblur Rapidly Resolves Single-Nucleotide Community Sequence Patterns
Amnon Amir, Daniel McDonald, José A. Navas-Molina et al. · mSystems · 2017 · 2K citations · Full text
New evidences on the altered gut microbiota in autism spectrum disorders
Francesco Strati, Duccio Cavalieri, Davide Albanese et al. · Microbiome · 2017 · 1K citations · Full text